[3]Tulloh R. Etiology, diagnosis, and pharmacologic treatment of pediatric pulmonary hypertension[J].Paediatr Drugs, 2009, 11(2):115-128.
[4]Sakuma M, Shirato K. Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension[J].Nippon Rinsho, 2008, 66(11):2157-2161.
[5]Humpl T, Reyes JT, Holtby H, Stephens D, Adatia I. Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open-label, pilot study[J].Circulation, 2005, 111(24):3274-3280.
[6]Raposo-Sonnenfeld I, Otero-Gonzalez I, Blanco-Aparici M, Ferrer-Barba A, Medranolopez C. Treatment with sildenafil, bosentan, or both in children and young people with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome[J].Rev Esp Cardiol, 2007, 60(4):366-372.
[8]Haworth SG, Hislop AA.Treatment and survival in children with pulmonary arterial hypertension:the UK Pulmonary Hypertension Service for Children 2001-2006[J].Heart 2009, 95(4):312-317.
[9]Krishnan U, Krishnan S, Gewitz M. Treatment of pulmonary hypertension in children with chronic lung disease with newer oral therapies[J].Pediatr Cardiol, 2008, 29(6):1082-1086.
[10]Kovacikova L, Zahorec M, Nosal M.Sildenafil as a pulmonary vasodilator after repair of congenital heart disease[J].Bratisl Lek Listy, 2007,108(10-11):453-454.
[11]Peiravian F, Amirghofran AA, Borzouee M, Ajami GH, Sabri MR, Kolaee S. Oral sildenafil to control pulmonary hypertension after congenital heart surgery[J].Asian Cardiovasc Thorac Ann, 2007,15(2):113-117 .
[13]Raja SG, Macarthur KJ, Pollock JC. Is sildenafil effective for treating pulmonary hypertension after pediatric heart surgery?[J].Interact Cardiovasc Thorac Surg , 2006, 5(1):52-54.
[14]Stocker C, Penny DJ, Brizard CP, Cochrane AD, Soto R, Shekerdemian LS. Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery[J].Intensive Care Med, 2003, 29(11):1996-2003.
[15]Schulze-Neick I, Hartenstein P, Li J, Stiller B, Naqdvman N, Hubler M, et al. Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease[J].Circulation, 2003,108 (Suppl 1):II167-173.
[16]Kothari SS, Duggal B. Chronic oral sildenafil therapy in severe pulmonary artery hypertension[J].Indian Heart J, 2002, 54(4):404-409.
[17]Latini G, Del Vecchio A, De Felice C, Verrotti A, Bossone E.Persistent pulmonary hypertension of the newborn: therapeutical approach[J].Mini Rev Med Chem, 2008, 8(14):1507-1513.
[18]Juliana AE, Abbad FC. Severe persistent pulmonary hypertension of the new born in a setting where limited resources exclude the use of inhaled nitric oxide: successful treatment with sildenafil[J].Eur J Pediatr, 2005, 164(10):626-629.
[19]Baquero H, Soliz A, Neira F, Veneqas ME, Sola A.Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study[J].Pediatrics, 2006,117(4):1077-1083.
[20]Shah PS, Ohlsson A. Sildenafil for pulmonary hypertension in neonates[J].Cochrane Database Syst Rev, 2007, 18 (3):CD005494.
[21]Shafig N, Reddy S, Pandhi P. Sildenafil for pulmonary hypertension: need for evidence generation[J].Int J Clin Pharmacol Ther, 2008, 46(12):644-651.
[22]Saxena A, Juneja R, Ramakrishnan S. Drug therapy of cardiac diseases in children[J].Indian Pediatr, 2009, 46(4):310-338.
[23]Raja SG, Danton MD, MacArthur KJ, Pollock JC. Effects of escalating doses of sildenafil on hemodynamics and gas exchange in children with pulmonary hypertension and congenital cardiac defects[J].J Cardiothorac Vasc Anesth, 2007, 21(2):203-207.
[24]de Souza AH, Cabral LM, Huf G.Current practices in the use of sildenafil for pulmonary arterial hypertension in Brazilian hospitals[J].BMC Res Notes, 2009, 2(30):1756-1761.
[25]Nahata MC, Morosco RS, Bradv MT.Extemporaneous sildenafil citrate oral suspensions for the treatment of pulmonary hypertension in children[J].Am J Health Syst Pharm, 2006, 63(3):254-257.